Advances in Hemophilia Treatment: From Genetics to Joint Health
Editat de E. Carlos Rodríguez-Merchánen Limba Engleză Paperback – 23 apr 2023
The first part is devoted to the disease’s pathophysiology (differentiating hemophilia A and B), genetics, pharmacotherapy – including replacement and non-replacement therapy – and gene therapy, as well as quality of life issues – also related to hemophilia carriers. The second part is then focused on joint problems, ranging from joint health assessment and pain control to surgical treatment of acute hemarthrosis and hemophilic arthropathy, i.e. radiosynovectomy, total joint arthroplasty and arthroscopic joint debridement.
Written by experts drawn from leading institutions involved in treatment of hemophilia andrelated joint problems, this book offers a valuable resource to hematologists, orthopedic surgeons, rehabilitation physicians, radiologists, and pharmacy researchers.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 528.11 lei 38-44 zile | |
| Springer International Publishing – 23 apr 2023 | 528.11 lei 38-44 zile | |
| Hardback (1) | 770.11 lei 22-36 zile | |
| Springer International Publishing – 23 apr 2022 | 770.11 lei 22-36 zile |
Preț: 528.11 lei
Preț vechi: 555.90 lei
-5% Nou
Puncte Express: 792
Preț estimativ în valută:
101.07€ • 104.98$ • 83.95£
101.07€ • 104.98$ • 83.95£
Carte tipărită la comandă
Livrare economică 29 ianuarie-04 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030939922
ISBN-10: 3030939928
Pagini: 173
Ilustrații: VIII, 173 p. 42 illus., 31 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.44 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030939928
Pagini: 173
Ilustrații: VIII, 173 p. 42 illus., 31 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.44 kg
Ediția:1st ed. 2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
1. Pathophysiology of hemophilia.- 2. Genetics of Hemophilia A and B.- 3. Inhibitors in Hemophilia A.- 4. Immune Tolerance In Patients with Hemophilia A.- 5. Hemophilia A: New drugs.- 6. Inhibitors in Hemophilia B.- 7. Immune Tolerance Induction in Hemophilia B.- 8. Hemophilia B: New Drugs.- 9. Management of Hemophilia Carriers.- 10. Pharmacoeconomic Aspects in Hemophilia.- 11. Assessment of Joint Health and Outcome Measures in Hemophilia.- 12. Musculoskeletal Medicine in Hemophilia.- 13. Management of Acute Hemarthrosis in Hemophilia (Including Joint Aspiration).- 14. Hemophilic Arthropathy: Radiosynovectomy.- 15. Hemophilic Arthropathy: Arthroscopic Joint Debridement.- 16. Hemophilic Arthropathy: Total Joint Arthroplasty.- 17. Hemophilic Arthropathy: Other Orthopedic Procedures.- 18. Gene Therapy in Hemophilia: Latest Advances.- 19.A Summary of the Recent Recommendations of the WFH.
Notă biografică
E. Carlos Rodríguez-Merchán is a Specialist in Orthopedic Surgery and “Emeritus” Consultant Orthopedic Surgeon currently working at the Department of Orthopedic Surgery, La Paz University Hospital, Madrid, Spain. Dr. Rodríguez-Merchán graduated from Complutense University with a degree in Medicine and Surgery in 1974, and subsequently completed a PhD in Medicine and Surgery. He is a former Associate Professor of Orthopedics at the Autonomous University of Madrid. Dr. Rodríguez-Merchán is the author of more than 300 articles in peer-reviewed PubMed-cited journals, as well as 11 books.
Textul de pe ultima copertă
This book offers a comprehensive and state of the art overview of hemophilia management by reviewing all most recent advances and cutting edge information in this fast evolving field. As hemophilia patients are often affected by joint problems it also provides clear guidance on the surgical treatment of musculo-skeletal manifestations.
The first part is devoted to the disease’s pathophysiology (differentiating hemophilia A and B), genetics, pharmacotherapy – including replacement and non-replacement therapy – and gene therapy, as well as quality of life issues – also related to hemophilia carriers. The second part is then focused on joint problems, ranging from joint health assessment and pain control to surgical treatment of acute hemarthrosis and hemophilic arthropathy, i.e. radiosynovectomy, total joint arthroplasty and arthroscopic joint debridement.
The first part is devoted to the disease’s pathophysiology (differentiating hemophilia A and B), genetics, pharmacotherapy – including replacement and non-replacement therapy – and gene therapy, as well as quality of life issues – also related to hemophilia carriers. The second part is then focused on joint problems, ranging from joint health assessment and pain control to surgical treatment of acute hemarthrosis and hemophilic arthropathy, i.e. radiosynovectomy, total joint arthroplasty and arthroscopic joint debridement.
Written by experts drawn from leading institutions involved in treatment of hemophilia and related joint problems, this book offers a valuable resource to hematologists, orthopedic surgeons, rehabilitation physicians, radiologists, and pharmacy researchers.
Caracteristici
Offers a state of the art overview of hemophilia management and related joint problems Cats new light on hemophilia’s pathophysiology, genetics, pharmacotherapy and gene therapy Written by experts from the leading institution involved in treatment of hemophilia and related joint problems